SLC26A4 and Hodgkins lymphoma: Although the variant is classified as likely benign according to the ACMG classification guidelines, we identified the variant three times in our cohort of genetically unexplained SLC26A4 cases and combined with the fact that it has been reported in a previous study (Pique et al. 2014), this suggests that the variant might actually contribute to the etiology of HL and EVA although not in a monogenic pattern.